Averion plans going private to cut outgoings
CRO Averion is planning to become a private company to reduce expenditure on auditor fees, which could realise savings of $805,000 (€561,000), and allow management to better focus on long-term goals.
Archives for September 6, 2009
Slump bad for North American APIs, but biotech to lead recovery
The global economic crisis has drastically reduced the growth of the North America API market, but brighter days are ahead according to new research by Global Markets Direct (GMD).
Merck’s post-merger management structure and a difference of opinion at LifeCycle Pharma – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including Merck’s post-merger management structure and a difference of opinion at LifeCycle Pharma.
Avid’s revenues rise 74%; discusses expansion plans
CMO Avid Bioservices’ revenues rose by 74 per cent to $2.1m (€1.5m) in Q2, generating a further $7m from its parent company, and it has plans to boost output and become a leader in mammalian cell culture production.
Cloud Packaging meets shorter run trend with Toll takeover
Cloud Packaging Solutions has said the acquisition of Toll Packaging will boost its ability to meet the increased demand for shorter packing runs triggered by the current global economic crisis.
Pacific Biometrics boosts biomarker biz with $4m loan
US CRO and central laboratory services provider Pacific Biometrics (PBI) has entered into a $4m (€2.7m) loan agreement that it says will help further the development of its contract biomarkers business.